Literature DB >> 30132957

Micro-RNAs as critical regulators of matrix metalloproteinases in cancer.

Somaye Noruzi1, Mitra Azizian2, Rezvan Mohammadi1, Seyede Atefe Hosseini1, Bahman Rashidi3, Yousef Mohamadi4,5, Abolfazl Nesaei6, Parvaneh Seiri7, Amirhossein Sahebkar8,9, Reza Salarinia1, Arad Mobasher Aghdam10, Hamed Mirzaei11.   

Abstract

Metastasis is known to be one of the important factors associated with cancer-related deaths worldwide. Several cellular and molecular targets are involved in the metastasis process. Among these targets, matrix metalloproteinases (MMPs) play central roles in promoting cancer metastasis. MMPs could contribute toward tumor growth, angiogenesis, migration, and invasion via degradation of the extracellular matrix and activation of pre-pro-growth factors. Therefore, identification of various cellular and molecular pathways that affect MMPs could contribute toward a better understanding of the metastatic pathways involved in various tumors. Micro-RNAs are important targets that could affect MMPs. Multiple lines of evidence have indicated that deregulation of various micro-RNAs, including miR-9, Let-7, miR-10b, and miR-15b, affects metastasis of tumor cells via targeting MMPs.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; matrix metalloproteinases; metastasis; micro-RNAs

Year:  2018        PMID: 30132957     DOI: 10.1002/jcb.27182

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  Let-7f miRNA regulates SDF-1α- and hypoxia-promoted migration of mesenchymal stem cells and attenuates mammary tumor growth upon exosomal release.

Authors:  Virginia Egea; Kai Kessenbrock; Devon Lawson; Alexander Bartelt; Christian Weber; Christian Ries
Journal:  Cell Death Dis       Date:  2021-05-20       Impact factor: 8.469

2.  Serum miR-125b levels associated with epithelial ovarian cancer (EOC) development and treatment responses.

Authors:  Zhonghua Chen; Xiaoli Guo; Shukai Sun; Caixia Lu; Liming Wang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

3.  Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin.

Authors:  Zahra Bolandghamat Pour; Mitra Nourbakhsh; Kazem Mousavizadeh; Zahra Madjd; Seyedeh Sara Ghorbanhosseini; Zohreh Abdolvahabi; Zahra Hesari; Samira Ezzati Mobasser
Journal:  BMC Cancer       Date:  2019-11-01       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.